Tetsuro Sasada

15PUBLICATIONS
32CO-AUTHORS
Predictive and prognostic markersGene and molecular therapyMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Medical biochemistry - amino acids and metabolites
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Apr 16, 2026
Dynamic changes in serum HER2-peptide-specific autoantibodies predict response to neoadjuvant therapy in HER2-positive breast cancer.

|Aug 29, 2024
Prognostic Significance of Plasma Neutrophil Extracellular Trap Levels in Patients with Non-Small Cell Lung Cancer Treated with Immune Checkpoint Inhibitors.

Shun Horaguchi, Yoshiro Nakahara, Yuka Igarashi

|Jan 12, 2024
Novel chimeric antigen receptor-expressing T cells targeting the malignant mesothelioma-specific antigen sialylated HEG1.

Taku Kouro, Naoko Higashijima, Shun Horaguchi

|Dec 14, 2023
Circulating cytokine signatures as a soluble biomarker of immune checkpoint inhibitor therapy in non-small-cell lung cancer.

Feifei Wei, Tetsuro Sasada

|Jul 11, 2023
Machine learning for prediction of immunotherapeutic outcome in non-small-cell lung cancer based on circulating cytokine signatures.

Feifei Wei, Koichi Azuma, Yoshiro Nakahara

|Jun 29, 2022
NY-ESO-1-specific redirected T cells with endogenous TCR knockdown mediate tumor response and cytokine release syndrome.

Mikiya Ishihara, Shigehisa Kitano, Shinichi Kageyama

Pageof 3

Frequent Collaborators

5 joint publications

Taku Kouro

4 joint publications

Shigeru Yutani

4 joint publications

Feifei Wei

2 joint publications

Shinjiro Sakamoto